News & Events
April 25, 2018
Ninth Annual Patient-Reported Outcome Consortium WorkshopWHAT: Ninth Annual Patient-Reported Outcome Consortium Workshop WHEN: April 25-26, 2018 WHERE: Sheraton Silver Spring, Silver Spring, MD CONTENT: The Ninth Annual Patient-Reported Outcome Consortium Workshop will be on Wednesday, April 25 and Thursday, April 26, 2018 at the Sheraton Silver Spring, in Silver Spring MD. A detailed agenda and logistics are currently being developed and...
April 11, 2018
2018 Annual International Neonatal Scientific WorkshopBethesda North Marriott Hotel & Conference Center, Maryland Agenda – Day 1, April 11, 2018 8:00 am – 12:00 pm INC Hemodynamic Adaptation Workgroup Meeting Heike Rabe and Janis Dionne, co-chairs 8:00 am – 12:00 pm INC BPD Workgroup Meeting Robin Steinhorn and Wolfgang Göpel, co-chairs 12:00 pm – 1:00 pm Lunch 1:00 pm –...
November 6, 2017 - November 7, 2017
Proceedings from Huntington’s Disease Regulatory Science Consortium (HD-RSC) Kick-Off Meeting, Nov. 6-7, 2017On November 6 and 7, 2017, in Silver Spring, MD, Critical Path Institute and CHDI Foundation welcomed participants from the pharmaceutical industry, academia, regulatory agencies, and advocacy groups to a kick-off meeting for the Huntington’s Disease Regulatory Science Consortium (HD-RSC). The meeting objectives were to solicit input from stakeholders on HD-RSC plans and deliverables, and...
September 26, 2017
Hemodynamic Adaptation (HA) Workgroup and Retinopathy of Prematurity (ROP) Workgroup Face-to-Face Meetings at Health CanadaDate: September 26, 2017 Where: Ottawa, Ontario (Can also participate via WebEx) The Hemodynamic Adaptation (HA) Workgroup and the Retinopathy of Prematurity (ROP) Workgroup face-to-face meetings will take place on September 26th, 2017. Thanks to INC’s representative Agnes Klein and her Health Canada colleagues, this workshop will take place at the Health Canada headquarters in Ottawa, Ontario. The HA Workgroup will...
September 26, 2017
Coalition Against Major Diseases 2017 Annual Meeting and Regulatory Science WorkshopSeptember 26, 2017 Overview and Objectives: The Coalition Against Major Diseases (CAMD) is a public-private partnership aimed at developing creating Drug Development Tools that can be applied to increase the efficiency of the development process of new treatments for Alzheimer disease (AD) and related dementias. The annual meeting, which is open to the public, brings...